CAT
48
-2
BF.B
47
-3
SE
86
-2
NWS
88
4
APD
40
-4
PSA
51
5
EQIX
67
2
NI
73
-5
PVH
54
-4
MAT
54
-2
UNM
54
-5
TGNA
48
-5
OKE
42
-4
PFE
39
-7
VTR
44
-3
MET
63
-3
TJX
51
-3
JBHT
35
-4
LUV
62
3
HPQ
52
-5
CAT
48
-2
BF.B
47
-3
SE
86
-2
NWS
88
4
APD
40
-4
PSA
51
5
EQIX
67
2
NI
73
-5
PVH
54
-4
MAT
54
-2
UNM
54
-5
TGNA
48
-5
OKE
42
-4
PFE
39
-7
VTR
44
-3
MET
63
-3
TJX
51
-3
JBHT
35
-4
LUV
62
3
HPQ
52
-5
Financhill
Back

Tonix Pharmaceuticals Holding Stock Predictions

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Buy
57

TNXP
Tonix Pharmaceuticals Holding

Last Price:
$37.57
Seasonality Move:
-14.14%

7 Day Trial

ALL ACCESS PASS

$ 7

The Future of Housing Is Being Built Now

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

Tonix Pharmaceuticals Holding Stock Forecast

  • Over the next 52 weeks, Tonix Pharmaceuticals Holding has on average historically fallen by 26.5% based on the past 13 years of stock performance.
  • Tonix Pharmaceuticals Holding has fallen lower in 12 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 92.31%
  • Is Tonix Pharmaceuticals Holding Stock Undervalued?
    The current Tonix Pharmaceuticals Holding [TNXP] share price is $37.69. The Score for TNXP is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • TNXP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Tonix Pharmaceuticals Holding Stock Go Up Next Year?

  • Over the next 52 weeks, Tonix Pharmaceuticals Holding has on average historically fallen by 26.5% based on the past 13 years of stock performance.

Tonix Pharmaceuticals Holding Stock Rating

Buy
57
Tonix Pharmaceuticals Holding (TNXP) is a Buy

Is Tonix Pharmaceuticals Holding overpriced?

  • Tonix Pharmaceuticals Holding has fallen lower in 12 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 92.31%

Tonix Pharmaceuticals Holding Stock Price History

Is TNXP stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNXP is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tonixpharma.com

52-Week Data

52-Week High:
560.00
52-Week Low:
6.76

Prediction Charts

Market Cap:
276.1M
Price in USD:
37.69
Volume:
1.1M
Beta:
2.51

Technical Analysis

SMA50:
20.99
SMA100:
20.34
SMA200:
21.45
52-Wk Change:
-93.07%

Stock Predictions

  • Is Tonix Pharmaceuticals Holding stock public?
    Yes, Tonix Pharmaceuticals Holding is a publicly traded company.
  • What is the Tonix Pharmaceuticals Holding stock quote today?
    The Tonix Pharmaceuticals Holding stock price is 37.69 USD today.
  • How to buy Tonix Pharmaceuticals Holding stock online?
    You can buy Tonix Pharmaceuticals Holding shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-8 19.25 18.94 19.43 18.60
May-9 19.15 18.83 19.94 18.45
May-12 18.84 19.19 19.65 18.50
May-13 19.35 20.18 21.10 18.78
May-14 20.36 22.08 22.96 20.36
May-15 22.20 23.10 23.39 21.03
May-16 25.17 28.00 30.20 25.00
May-19 27.45 26.60 28.78 26.10
May-20 27.16 29.90 30.74 25.11
May-21 30.70 28.33 32.69 28.05
May-22 29.05 26.40 31.50 25.40
May-23 26.15 28.93 29.20 26.01
May-27 29.90 36.99 37.84 29.74
May-28 36.98 37.69 37.82 34.50

Tonix Pharmaceuticals Holding Earnings

Tonix Pharmaceuticals Holding Earnings Report: Per Share Tonix Pharmaceuticals Holding Earnings Q1 Q2 Q3 and Q4 last year and next year.

Tonix Pharmaceuticals Holding Forecast Revenue Growth

Tonix Pharmaceuticals Holding Stock Analysis: Historical quarterly revenues per share for Tonix Pharmaceuticals Holding and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $732.91 per share, an increase next quarter of $2.04 per share, a decrease this year of $8.50 per share, and an increase next year of $7.22 per share.

* Tonix Pharmaceuticals Holding stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.